Tags: Drug.

Boceprevir (INN trade name Victrelis) is a protease inhibitor used as a treatment for hepatitis C genotype 1. It binds to HCV nonstructural 3 NS3 (HCV) active site.It was being developed by Schering-Plough but is now being developed by Merck since Schering was acquired in 2009. It was approved by the FDA on May 13 2011.

Boceprevir.svg
ATC prefix
J05
ATC suffix
AE12
CAS number
394730-60-0
FDA UNII code
89BT58KELH
IUPAC name
(1R5S)-N-[3-Amino-1-(cyclobutylmethyl)-23-dioxopropyl]-3-[2(S)-[[[(11-dimethylethyl)amino]carbonyl]amino]-33-dimethyl-1-oxobutyl]-66-dimethyl-3-azabicyclo[3.1.0]hexane-2(S)-carboxamide
PubChem
10324367

Loading...

This page contains content from the copyrighted Wikipedia article "Boceprevir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.